Literature DB >> 13214

Studies on antianaphylactic agents. 5. Synthesis of 3-(1H-tetrazol-5-yl)chromones, a new series of antiallergic substances.

A Nohara, H Kuriki, T Saijo, H Sugihara, M Kanno, Y Sanno.   

Abstract

A number of 3-(1H-tetrazol-5-yl)chromones were synthesized and found to have antiallergic activity in the rat passive cutaneous anaphylaxis (PCA) test. These compounds are active when administered orally in rats and of possible value for the treatment of asthma.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 13214     DOI： 10.1021/jm00211a030

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


  5 in total

1.  7-Diethyl-amino-2-propyl-sulfan-yl-3-(1H-1,2,4-triazol-1-yl)-4H-thio-chromen-4-one.

Authors:  Chen Li; Guang Yan Yu; Xin Tian; Song Li; Tao Xiao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-04-18

2.  The anchoring of a Cu(ii)-salophen complex on magnetic mesoporous cellulose nanofibers: green synthesis and an investigation of its catalytic role in tetrazole reactions through a facile one-pot route.

Authors:  Pouya Ghamari Kargar; Ghodsieh Bagherzade
Journal:  RSC Adv       Date:  2021-05-27       Impact factor: 4.036

3.  Design, Synthesis, and In Vitro Antimicrobial Evaluation of Fused Pyrano[3,2-e]tetrazolo[1,5-c]pyrimidines and Diazepines.

Authors:  Sankari Kanakaraju; P Sagar Vijay Kumar; Bethanamudi Prasanna; G V P Chandramouli
Journal:  ISRN Org Chem       Date:  2013-08-21

4.  Reactions of 3-formylchromone with active methylene and methyl compounds and some subsequent reactions of the resulting condensation products.

Authors:  Renata Gasparová; Margita Lácová
Journal:  Molecules       Date:  2005-08-31       Impact factor: 4.411

Review 5.  Synthesis of heterocyclic analogs of isoflavone and homoisoflavone based on 3-formylchromone.

Authors:  S S Shatokhin; V A Tuskaev; S Ch Gagieva; É T Oganesyan
Journal:  Russ Chem Bull       Date:  2021-07-14       Impact factor: 1.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.